Dementia 2019 Conferences, Dementia congress, dementia conferences, Euro Dementia Events, Alzheimer Disease conferences, neurology Events, neuroscience 2019, psychiatry conferences, neuroscience conferences, Rome, Italy, Europe

Previous Speakers

Barbara F Fisher

Director United Psychological Services USA

Howard Federoff

Health Affairs, Irvine Health System University Califiornia at Irvine, USA

Frank Galimidi

New Beginnings Recovery Center,, USA

Maia Machvariani-Tsereteli

Iv. Javakhisvili Tbilisi State University , Georgia

Diana Kljenak

Ontario Psychiatric Association, Canada

Sepi Shokouhi

University Institute of Imaging Science, USA

Hemanth Rao

The Neurological Institute, USA

Lucia M. Vaina

Boston University College of Engineering, USA

Recommended Global Neuroscience Webinars & Conferences

Europe & UK

Alzheimers-2025, France NEUROSCIENCE_2025, France Stroke Meeting 2025, France Euro Dementia 2025, Germany Mental Health Congress 2025, France

Asia Pacific & Middle East

Neuroscience-2025, UAE

Canada

Neuroscience Congress 2025, Canada Neurogenetics 2025, Canada Stroke Summit 2025, Canada

Euro Dementia Congress 2019

About Conference

Conference Series llc LTD through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community.

Conference Series llc LTD Organizes 1000+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board members.

It’s with great pleasure and great honor to invite you to the “15^th International Conference and Exhibition on Alzheimer’s Disease, Dementia & Aging” scheduled during April 22-23 2019 at Rome, Italy.

Welcome to most exciting and fascinating city, Rome, Italy!

Within this splendid setting, we plan to deliver a conference that will exceed your expectations. Our event aims to make people with dementia feel safe and to create a familiar environment for them.

During this year’s Conference, we hope that you will seize the opportunity to rekindle on-going connections and spark new ones with your colleagues from around the globe.

The Conference will be organized around the theme “Scientific Innovations, Research Ideologies & Clinical Practice in Alzheimer’s Disease & Dementia”

Euro Dementia Congress 2019 anticipates more than 500 participants around the globe to experience thought provoking Keynote lectures, Oral & Poster presentations. This year conference will offer ample opportunities for all stakeholders working on Dementia, Alzheimer’s and neurology to expose their research work.

Our conference aims to gather the Researchers, principal investigators, experts, neurologists and researchers working on brain from both academia and health care industry, Business Delegates, Scientists and students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.

This year’s Conference program, coupled with the Business Opportunity Exchange, is an event you can’t afford to miss!

Why to attend?

15^th International Conference and Exhibition on Alzheimer’s Disease, Dementia & Aging is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading Neurologists, health professionals involved in the profession and practice of neuroscience. The event will also reflect interest of specialists in the clinical research on dementia. Conference series organizing this international event for people to take part and gain a better understanding of such diseases, to access treatment as well as information, advice and support and to have their health monitored more closely.

This International meeting is an effort to make possible interactions among world leading scientists, research scholars, professionals, young researchers from different parts of the world to exchange their knowledge and conduct symposia, show experiments with new innovative techniques that disseminate information about clinical tradition, best practices, skills and knowledge in the field of neuroscience. In Euro Dementia 2019, international symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Dementia and Neurology.

Benefits:

Accepted abstracts will be published in Journal of Alzheimer’s Disease & Parkinsonism and provided with DOI.
Global networking: In transferring and exchanging Ideas.

Target Audience:

Neurologists and Directors
Physicians
Neuroscientists
Specialists
Researchers
Health care professionals
Professors
Industrial Experts
Neurosurgeons
Psychiatrist
Nutritional Scientists
Lecturers and Students from Academia in the study of Dementia
Students from Academia in the research of Neurology
Neuro-Physiotherapists

Sessions/Tracks

The word ‘dementia’ describes a set of symptoms include memory loss and difficulties with thinking or reasoning that reduce a person ability to perform everyday activities. Dementia is mainly caused when the brain is damaged by diseases, such as Alzheimer’s disease or a series of strokes. This disease mainly affects people over the age of 65 and the likelihood of developing dementia increases significantly with age. However, dementia can affect younger people too.

Euro Dementia Congess 2019 is focussing on various researches, to develop technologies to help people with dementia live as well as they can, for as long as they can. This research is crucial for the hope of a cure and for improvements in treatments and care. Through this Alzheimer’s disease and Dementia meeting, it will offer an extraordinary open door for members, agents ecumenically to meet, arrange, and see nascent logical connections for well suited adjust in life.

The conference includes following scientific sessions:

Session 1: Dementia

Dementia is not a specific disease. It's an overall term that describes a wide range of symptoms associated with a decline in memory or other thinking skills severe enough to reduce a person's ability to perform everyday activities. Alzheimer's disease. Vascular dementia, which occurs after a stroke, is the second most common dementia type. But there are many other conditions that can cause symptoms of dementia, including some that are reversible, such as thyroid problems and vitamin deficiencies. Dementia is a syndrome that involves severe loss of cognitive abilities as a result of disease or injury. Dementia caused by traumatic brain injury is often static, whereas dementia caused by neurodegenerative disorders, such as Alzheimer's disease, is usually progressive and can eventually be fatal. Dementia can be grouped based on the part of brain being affected. it is roughly true that the earliest symptoms in "cortical" dementia include difficulty with high-level behaviour’s such as memory, language, problem-solving and reasoning; these functions tend to be less impaired in "subcortical" dementia. Cortical dementia occurs because of damage in the cerebral cortex, the outer layer of the brain. They play a critical role in memory and language. The symptoms usually include severe memory loss. Alzheimer's and Creutzfeldt-Jakob disease are two forms of cortical dementia. Subcortical dementia occurs due to the damage to the part of the brain beneath the cortex. The person suffering from it can show changes in their speed of thinking. Usually, people with subcortical dementia don't have forgetfulness and language problems. Parkinson's disease, Huntington's disease, and HIV are two forms subcortical dementia.

Mixed dementia
Frontotemporal dementia
Neurogenesis in dementia
Global prevalence of dementia
Signs and symptoms of dementia
Primary mental health care and nursing
Novel therapeutics technology
Novel therapeutics strategies for Dementia

21^st World Congress on Neurology and Therapeutics, March 15-17, 2018 London, UK; 22^nd International Conference on Neurology & Neurophysiology, April 23-24, 2018 Rome, Italy; 23^rd International Conference on Neurology and Neurosurgery, April 23-24, 2018 Rome, Italy; 24^th International Conference on Neuroscience and Neurochemistry, May 24-25, 2018 Barcelona, Spain; 3^rd International Conference on Spine and Spinal Disorders, June 11-12, 2018 London, UK; 25^th World Congress on Neurology & Neuroscience, June 18-20, 2018 Dublin, Ireland; 7^th International Conference on Addictive Disorders & Addiction Therapy, July 16-18, 2018 London, UK; 4^th International Conference on Epilepsy & Treatment, August 29-30, 2018 Zurich, Switzerland; 4^th World Congress on Parkinson’s & Huntington Disease, August 29-30, 2018 Zurich, Switzerland.

Related Association:

USA and Canada:

Acoustic Neuroma Association; Aicardi Syndrome Foundation; Alternating Hemiplegia of Childhood Foundation; Alzheimer's Drug Discovery Foundation; Alzheimer's Association and Alzheimer's; Foundation of America; American Association of Health and Disability; American Autoimmune Related Diseases Association; American Behcet's Disease Association and American Brain Coalition

European Union and UK:

ALS Association and ALS Therapy Development Institute; Attention Deficit Disorder; Association and Autism National Committee; Carter Center for Brain Research in Holoprosencephaly; Lowe Syndrome Association; The Alzheimer Society of Ireland; Alzheimer Society London; Alzheimer Society Middlesex

Asia-Pacific and Middle East:

International Radio Surgery Association; Asian Society Against Dementia; Alzheimer And Related Dementia Society Nepal; Mental Illness; Dementia and Family in China; Alzheimer Society of B.C.; Grey zone - Coping with senility in Japan; ARDSI Kolkata

Session 2: Dementia with Lewy body

Lewy body is also known as dementia with Lewy bodies, with Lewy body dementia is the second most common type of progressive dementia after Alzheimer's disease dementia. Protein deposits, called Lewy bodies, develop in nerve cells in the brain regions involved in thinking, memory and movement (motor control).

Lewy body dementia is also causes a progressive decline in mental abilities. The people with Lewy body dementia may experience visual hallucinations and changes in the alertness and attention and other effects include Parkinson's disease-like symptoms such as rigid muscles, slow movement and tremors.

Risk factor of vascular dementia
Antipsychotic medications
Antipsychotic medications
Palliative care in vascular dementia
Autophagy
Synucleinopathies

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 3: Alzheimer’s Diseases

Alzheimer's Disease is irreversible and decimates cerebrum cells, making thinking capacity and memory weaken. Alzheimer's infection is a dynamic, degenerative mind ailment and the most widely recognized type of dementia, a gathering of brain disorders that influence a man's memory, considering and capacity to connect socially. Dementia and Alzheimer's infection isn’t the same. Dementia is a general term used to depict indications that effect memory, execution of day by day exercises, and correspondence capacities. Alzheimer's infection is the most widely recognized kind of dementia. Alzheimer's illness isn't a typical piece of maturing. We are leading exploration into the part of aggravation in Alzheimer's sickness to discover potential focuses for remedial mediation. The Dominantly Inherited Alzheimer Network is the main aim to discover biomarkers for Alzheimer's Diseases that are perceptible some time before the underlying clinical side effects. Members experience cerebrum checks and clinical evaluations and give blood and spinal liquid to explore. Presently utilizing hereditary linkage ways to deal with endeavor to distinguish these modifier qualities, which may give helpful focuses to the treatment of Alzheimer's sickness.

Role of Plaques and Tangles
Diagnostic and Statistical Manual of Mental Disorders
Mental Diseases
Dominantly Inherited Alzheimer Network (DIAN) study
Causative Genetic Mutation

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 4: Parkinson’s Diseases

Parkinson's ailment (PD) is an unending and dynamic neurological disorders that influence engine work, causing bradykinesia, postural unsteadiness, inflexibility and tremor very still. Side effects grow progressively, making start finding troublesome. PD likewise has a few non-engine highlights, including psychological wellness issues, rest unsettling influences and autonomic aggravations. At introduce, there is no cure for PD. The treatment is, subsequently, gone from treating side effects. There are right now two fundamental ways to deal with enhanced dopaminergic action inside the mind: expanding dopamine emission with exogenous operators and focusing on related neurotransmission pathways. Levodopa is the regular metabolic antecedent of dopamine and is profoundly successful for treating PD indications. Side effects of Parkinson's Diseases are normally overseen utilizing a specific dopamine receptor agonist. While these medications are valuable in beginning time Parkinson's, they tend to lose viability in later sickness stages

Prevention of Parkinson’s Disease by Immune gene
Disease beyond Genetic Mutations

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 5: Vascular Dementia

Vascular dementia is the second most regular reason for dementia after Alzheimer's Diseases. Vascular changes that begin in mind territories that assume a key part in putting away and recovering data may cause memory misfortune that looks especially like Alzheimer's illness. Vascular dementia is a decrease in intuition abilities caused by conditions that square or diminish blood stream to the cerebrum, denying mind cells of fundamental oxygen and supplements. Deficient blood stream can harm and, in the end, dead cells anyplace in the body. The mind has one of the body's richest systems of veins and is particularly helpless. In vascular dementia, changes in speculation abilities now and then happen abruptly following strokes that square significant cerebrum veins. A developing number of specialists lean toward the expression "Vascular Cognitive Impairment (VCI)" to "vascular dementia”. A few examinations have discovered that vascular changes and other cerebrum irregularities may associate in ways that improve the probability of dementia finding. The analysis of dementia or gentle psychological impedance is affirmed by neurocognitive testing, which includes a few hours of composed or mechanized tests that give point by point assessment of reasoning abilities, for example, judgment, arranging, critical thinking, thinking and memory

Frontotemporal Dementia
Subcortical vascular dementia
Vascular Contributions to Cognitive Impairment and Dementia
Post-stroke dementia
Multi-infarct dementia
Pathobiology of vascular dementia

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 6: Brain Diseases

Brain diseases come in different forms of Infections, trauma, stroke, seizures, and tumors are some of the major categories of brain diseases. Here's an overview of various diseases of the brain.

Migraine
Attention deficit hyperactivity disorder
Motor neuron disease
Bipolar disorder
Arteriovenous malformation.
Encephalitis
Seizures
Trauma
Brain abscess

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 7: Childhood Trauma and Dementia

New research recommends there is a solid relationship between initial childhood trauma, for example, that accomplished by the stolen ages, and dementia. There is an expansive agreement demonstrating that childhood trauma is fundamentally associated with the improvement of sorrow. There is a solid connection between a high introduction to early life stress and affliction, that incorporates individuals that were a piece of the stolen ages, and the probability of being determined to have dementia sometime down the road. Psychic trauma is any psychological disorders that unexpectedly overpowers the ability to give a negligible feeling of wellbeing and integrative wholeness, bringing about overpowering nervousness or defenselessness, or its danger, and creating a continuing change in the psychic organization. Childhood trauma can influence mental and physical wellbeing into adulthood

Childhood Trauma and PTSD Symptoms
Psychological Therapies
Childhood trauma with cognitive function in healthy adults
Post-traumatic stress disorder and Alzheimer’s disease

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 8: Neurological Diseases

Neurological disorders are maladies of the focal and fringe sensory system. At the end of the day, spinal rope, cranial nerves, fringe nerves, nerve roots, autonomic sensory system and neuromuscular intersection. These disarranges incorporate epilepsy, Alzheimer illness and different dementias, cerebrovascular sicknesses including stroke, headache and other migraine issue, various sclerosis, Parkinson's infection, neuroinfectious, mind tumors, awful scatters of the sensory system because of head injury, and neurological issue due to hunger. Neurological manifestations may happen because of the contamination itself or because of a safe reaction. Countless individuals worldwide are influenced by neurological disarranges. Alzheimer's sickness is the most widely recognized reason for dementia and may add to 60– 70% of cases.

Chronic Neurological Diseases
Neurocutaneous Syndromes
Epilepsy and Seizures
Cerebral Aneurysm
Muscular Dystrophy

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 9: Neurodegenerative Diseases

Neurodegenerative sicknesses are crippling, and it is a heterogeneous gathering of disarranges of serious conditions that outcome in dynamic degeneration. Neurodegenerative maladies cause issues with development called ataxias, or mental working called dementias. Neurodegenerative infections happen when nerve cells in the mind or fringe sensory system lose work after some time and at last pass on. Although medicines may help diminish a portion of the physical or mental side effects related with neurodegenerative infections, there is right now no cure or approach to moderate ailment movement. The danger of being influenced by a neurodegenerative increment drastically with age. A greatly little extent under five level of neurodegenerative infections are caused by hereditary changes. This makes a basic need to enhance our comprehension of what causes neurodegenerative infections and grow new methodologies for treatment and counteractive action.

Alzheimer’s disease
Huntington’s disease
Amyotrophic lateral sclerosis (ALS)
Motor neuron disease

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 10: Neurovascular Dysfunction and Neurodegeneration

Vascular insults can start a course of Molecular event occasions prompting neurodegeneration, psychological disorders, and dementia. Here, the molecular mechanisms and cell in cerebral veins pathophysiological occasions prompting disturbance of the blood-cerebrum obstruction and cerebral blood stream dysregulation and the neurovascular unit, which all may add to the beginning and movement of dementia and Alzheimer's disease. From the most punctual phases of improvement, when cerebral neurogenesis and angiogenesis are weaved, to the finish of life, the interaction between neural frameworks and vascular of the cerebrum is basic in wellbeing and infection. Cerebral blood stream control is fundamental for ordinary mind work. The mammalian mind has developed an exceptional system for CBF control known as neurovascular coupling.

Neurovascular pathways to neurodegeneration
Neurovascular regulation in the normal brain
Cerebral microvasculature
Dysfunction of the blood–brain barrier
Neurovascular coupling
Dermal Neurovascular Dysfunction

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 11: Neuroimaging Biomarkers

Alzheimer’s disease Biomarkers, with emphasis on cerebrospinal fluid biomarkers and neuroimaging. Mild Cognitive Impairment (MCI) of Neuroimaging-biomarkers allow an early diagnosis in preclinical stages of Alzheimer’s disease. Biomarker changes in patients with late-onset AD, including findings from studies using structural and functional magnetic resonance imaging (MRI), advanced MRI techniques (diffusion tensor imaging, magnetic resonance spectroscopy, perfusion), positron emission tomography with fluorodeoxyglucose, amyloid tracers, and other neurochemical tracers, and CSF protein levels. The dynamic measures of these imaging biomarkers are used to predict the disease progression in the early stages and improve the assessment of therapeutic efficacy in these diseases in future clinical trials

Neurogenesis & Neuron Regeneration
Structural Neuroimaging
Neuropathology
Cerebrospinal fluid biomarker
Structural and functional biomarkers

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 12: Neuropharmacology

Neuropharmacology is an extremely wide locale of science that includes numerous parts of the sensory system from single neuron control to whole ranges of the cerebrum, spinal line, and fringe nerves. To better comprehend the premise behind medication advancement, one should first see how neurons speak with each other. This article will concentrate on both behavioral and atomic neuropharmacology; the real receptors, particle channels, and neurotransmitters controlled through medication activity and how individuals with a neurological issue advantage from this medication activity.

Neuroscience and neuropharmacology
Neurochemical interaction
Molecular neuropharmacology
Behavioral neuropharmacology
Advance research in neuropharmacology

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 13: Dementia Nursing

People with vascular dementia have different mental element shortfalls that incorporate every memory hindrance, that influences the adaptability to discover new data or review data already learned, and one or extra of the ensuing side effects aphasia, apraxia, agnosia, or official brokenness to such an extent that the mental element shortages adversely affect social or action working with a major decrease in past abilities. Furthermore, people with dementia commonly experience the ill effects of comorbid conditions that extra confuse mind and block best results. Along these lines, creating caregiving techniques individuals with vascular dementia is pressing, given this expanding commonness and consequently the related weight that dementia places not just on the people, however on the parental figures, relations, and thusly the assets of the human services framework. Traditional perspectives bearing on geriatric nursing ordinarily paint a picture of the care as being moderate paced certain and less requesting than intense care. Be that as it may, care of the matured, and especially those with vascular dementia, is normally confounded, unusual, and flimsy.

Dementia nursing care plan
Music therapy in dementia
Physiotherapy for dementia
Clinical features of dementia
Therapeutic interventions in dementia

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 14: Alzheimer Disease and Cellular Mechanisms

Most continuous endeavors to battle Alzheimer Disease are centered around treating its clinical symptoms, however the neuropathologic changes fundamental show up decades sooner and turn out to be basically irreversible when the sickness achieves its clinical stages.This requires treating at preclinical stages, which requires a superior comprehension of the essential instruments prompting Alzheimer Disease pathology. Alzheimer's infection is a complex hereditary issue that is the main source of dementia in the elderly. Atomic confirmation raised the presumptions that trafficking of the amyloid precursor protein is under control of insulin flagging. Most progressing endeavors to battle Alzheimer infection are centered around treating its clinical side effects, however the neuropathologic changes fundamental show up decades sooner and turn out to be basically irreversible when the ailment achieves its clinical stages.

Fixing Genetic risk for Alzheimer’s
Medial Temporal Lobe
Nervous System Disease
Neurofibrillary Degeneration

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 15: Alzheimer’s and the Brain

The brain ordinarily therapists to some degree in solid maturing in any case, shockingly, does not lose neurons in huge numbers. In Alzheimer's sickness, be that as it may, harm is across the board, the same number of neurons quit working, lose associations with different neurons, and pass on. Alzheimer's disturbs forms fundamental to neurons and their systems, including correspondence, digestion, and repair. Acetylcholine is a neurotransmitter that is insufficient in individuals with Alzheimer's, the place beginning memory misfortune is trailed by more far reaching changes in considering and conduct that prompt lost freedom. Numerous molecular and cell changes happen in the mind of a man with Alzheimer's illness

Amyloid Plaques
Neurofibrillary Tangles
Chronic Inflammation
Vascular Contributions to Alzheimer’s Disease
Loss of Neuronal Connections and Cell Death

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 16: Alzheimer’s Clinical Trials and Studies

To evaluate the safety and efficacy of an oral investigational drug in individuals who are asymptomatic and at-risk for Alzheimer's disease and investigating the effect of crenezumab infusion on Alzheimer's disease progression in individuals with prodromal or mild Alzheimer's disease. Presently the clinical trials and studies are mainly concentrates on Alzheimer’s Disease & Down syndrome, aging to have the best chance of changing the outlook for people with dementia promising ideas must be driven through the development process and into clinical trials in people as quickly as possible.

Targeting Amyloid
Ramping Up the Immune System
Non-Medication Approaches
Treatment trials
Diagnostic studies

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 17: Medical Biotechnology and Alzheimer’s disease

Alzheimer's Disease as a dynamic and fatal neurodegenerative disease speaks to an immense neglected requirement for treatment. The low viability of current treatment techniques isn't just because of low medication intensity yet in addition because of the nearness of different hindrances in the conveyance courses. One of the fundamental boundaries is the blood brain boundary. The expanding predominance of Alzheimer's Diseases and the low viability of ebb and flow treatments have expanded the measure of research on unwinding of sickness pathways and advancement of treatment techniques. One of the fascinating regions for the last subject is biotechnology and their applications. Nanotechnology is a standout amongst the most vital field in biotechnology and has a noteworthy part in the improvement of novel remedial modalities with expanded adequacy. In the nanotechnology field, materials are designed with utilitarian association on the nanoscale. Every one of the materials are utilized for association and incitement of organic frameworks at the atomic level to instigate physiological reactions. One of the primary issues concerning the treatment of neurodegenerative diseases is identified with medicate conveyance

Alzheimer disease drug discovery
Molecular and Cellular Basis of Neurodegeneration
Vaccine against Alzheimer’s disease
Biology of Ageing

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 18: Diagnostic Alzheimer

Doctors can't analyze Alzheimer's Disease until after death, when they can nearly inspect the brain under a magnifying instrument. However, they can utilize tests to decide out different conditions that may cause similar symptoms. Early, exact finding is advantageous for a few reasons. Starting treatment ahead of schedule in the illness procedure may help protect day by day working for quite a while, even though the hidden Alzheimer's procedure can't be ceased or switched. Alzheimer's dementia comes about because of the dynamic misfortune (degeneration) of brain cells. This movement may appear in an assortment of courses in brain scans. At present researchers are exploring a few ailment markers and demonstrative tests, for example, qualities, infection related proteins and imaging methods, which may precisely and dependably show whether you have Alzheimer's dementia or not. whatever, right now more research on these tests is important for future

Diagnostic Tests
Neuropsychological testing
Treatments for Behavior
Biomarker Research
Precision Medicine for Alzheimer Disease

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 19: Molecular Genetics and Biology of Dementia

Molecular biological research has considerably deepened our understanding of the pathophysiological basis of Alzheimer's dementia. Considerable progress has been made in our understanding of the genetics and molecular biology of dementia. Some genetic risk factors have been identified so far, but only a small proportion of AD cases can be explained by specific gene mutations. Genes may be related to disease in two ways: through autosomal-dominant mutations, in themselves sufficient to cause the disease alternatively, gene variations (polymorphisms) may indirectly increase disease risk without being sufficient in themselves to cause the disorder.

Molecular Genetics of Frontotemporal Dementia
Molecular Genetics of Neurodegenerative Dementias
Human stem cell models of dementia
Fixing Genetic risk for Alzheimer’s

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 20: Dementia Care and Consulting

Caring for a person with dementia influences distinctive individuals in various ways. In any case, caring can also be both physically and rationally debilitating. It influences all aspects of your life and can influence you to feel separated, pushed and at times even discouraged. You may also have your own physical and psychological wellness needs, which you and others may neglect when you are tending to another person. There are numerous positive things about caring. These incorporate adapting new aptitudes, expanding on existing ones, reinforcing connections, having a feeling of pride in what you are doing, and supporting somebody who is imperative to you. Furthermore, because a man has dementia, it doesn't mean there won't in any case be great circumstances for you to share

Dealing with Dementia Behaviour
Dementia Risk and Preventions

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 21: Novel Therapeutics

Novel therapeutics is a standout amongst the most energizing uses of data preparing frameworks is in diagnostics and treatment. This is not astonishing, given that illness analysis is in its center a data handling undertaking that finishes with a choice. In numerous infections, the conclusion can be performed in singular cells.

Novel therapeutics strategies for Dementia
Novel therapeutics technology
Novel therapeutics molecule
Anti-dementia drugs
Novel drug target for the treatment of dementia

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Session 22: Neuro Oncology and Central Nervous System

It is a branch of Medical Sciences majorly deals with Neuro tumors. Deals with Studies related to Brain and Spinal cord neoplasms. Neurooncology and Pediatric Neuro-oncology are the two different Concepts that differentiate the determining methodology of Neuro tumors. Neuro-oncology mainly includes especially related topics like Radiation therapy, Neurosurgery, Neuroimaging, social, Psychological, Neuropathology and psychiatric aspects.

Spine Cancer and Spine Cancer Treatment

Glioblastoma

Meningioma

Brain Stem Tumors

Malignant Brain Cancers and Brain Metastasis

Pediatric Neuro Oncology

Astrocytoma

Neurotoxicity

Risk Factors

Radiation Therapy And Chemotherapy

Related Association:

USA and Canada:

European Union and UK:

Asia-Pacific and Middle East:

Market Analysis

It is our pleasure to welcome you to the Euro Dementia Congress 2019 to be held in Rome, Italy from April 22-23, 2019.

Dementia is general term for memory misfortune and other intellectual capacities sufficiently genuine to meddle with everyday life. Alzheimer's illness represents 60 to 80 percent of dementia cases.

This gathering will build information, offer help, help learning and enable families and carers to search out relevant administrations for their adored one and to build up the most ideal home condition to help recuperation from this mind boggling and decimating maladies.

Alzheimer's disease is the most common form of dementia. The proportions of those with different forms of dementia can be broken down as follows:

Alzheimer's disease: 62%

Vascular dementia: 17%

Mixed dementia: 10%

Lewy-body dementia: 4%

Fronto-temporal dementia: 2%

Parkinson's dementia: 2%

Other: 3%

Why Rome??

Rome was also ranked in 2014 as 32nd in the Global Cities Index, being the highest-ranking city in Italy with a 2005 GDP of €94.376 billion (US$121.5 billion the city produces 6.7% of the national GDP (more than any other single city in Italy. Rome also had a 2003 GDP per capita of €29,153 (US$37,412), which was second in Italy, (after Milan), and is more than 134.1% of the EU average GDP per capita. Rome, on the whole, has the highest total earnings in Italy, reaching €47,076,890,463 in 2008, On a global level, Rome's workers receive the 30th highest wages in 2009, coming three places higher than in 2008, in which the city ranked 33rd. The Rome area had a GDP amounting to $167.8 billion, and $38,765 per capita.

Rome has 22 Universities and 217 hospitals, 381356 health care professionals including 28316 physicians and 32553 clinics and hospitals. The municipal government operates public health facilities across the city's territory, with a total of 770 primary health care units (UBS), ambulatory and emergency clinics and 17 hospitals. The Municipal Secretary of Healthcare Industry has 59,000 employees, including more than 8,000 physicians and 12,000 nurses. Italian Healthcare system is 3rd place according to 2014 globally having life expactancy of 82.09.

Rome is the principal railway node for central Italy. Rome's main railway station, Termini, is one of the largest railway stations in Europe and the most heavily used in Italy, with around 400 thousand travellers passing through every day. The second-largest station in the city, Roma Tiburtina, has been redeveloped as a high-speed rail terminus.

Rome is served by three airports. The intercontinental Leonardo da Vinci International Airport is Italy's chief airport, is located within the nearby Fiumicino, south-west of Rome. The older Rome Ciampino Airport is a joint civilian and military airport. It is commonly referred to as "Ciampino Airport", as it is located beside Ciampino, south-east of Rome. A third airport, the Roma-Urbe Airport, is a small, low-traffic airport located about 6 km (4 mi) north of the city centre, which handles most helicopter and private flights.

Why to attend???

According to WHO 47.5 million people have dementia and every year 7.7 million new cases are appearing. By 2030 total cases of dementia is projected to be 75.6 million and almost triple by 2050 to 135.5 million. Alzheimer’s disease contributes 60-70 % of cases in dementia and second most common condition of dementia is vascular dementia which contributes 20% of cases all over the world. Total estimated cost of dementia is 818 billion US $ in 2015.

With members from around the world focused on learning about various Alzheimer’s disease and how to prevent the disorders. This is your best opportunity to reach the largest assemblage of participants from the entire world.

At the Dementia conferences and from the eminent people speech, you can update your knowledge about current situation of Dementia research and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Dementia fields are hallmarks of this conference.

For more details please visit- https://alzheimers-dementia.neurologyconference.com/

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://alzheimers-dementia.neurologyconference.com/sponsors.php

Conference Highlights:

Dementia

Dementia with Lewy body

Alzheimer’s Diseases

Parkinson’s Diseases

Vascular Dementia

Brain Diseases

Childhood Trauma and Dementia

Neurological Diseases

Neurodegenerative Diseases

Neurovascular Dysfunction and Neurodegeneration

Neuroimaging Biomarkers

Neuropharmacology

Dementia Nursing

Alzheimer Disease and Cellular Mechanisms

Alzheimer’s and the Brain

Alzheimer’s Clinical Trials and Studies

Medical Biotechnology and Alzheimer’s disease

Diagnostic Alzheimer

Molecular Genetics and Biology of Dementia

Dementia Care and Consulting

Novel Therapeutics

Neuro Oncology and Central Nervous System

Alzheimer Association & Societies around the Globe:

Alzheimer's Australia

Albanian Alzheimer Society

Association de Lucha contra el Mal de Alzheimer

Foundation Alzheimer Aruba (FAA)

Alzheimer's Australia

Alzheimer Austria

Alzheimer Support Group

Alzheimer Society of Bangladesh

Barbados Alzheimer's Association Inc.

Alzheimer’s and Dementia Association of The Cayman Islands

Ligue National Alzheimer Liga

Alzheimer's Family Support Group

Association Bolivian de Alzheimery Otras Dementias

FEBRAZ - Federico Brasilia de Associaçãoes de Alzheimer

Corporation Alzheimer Chile

Alzheimer's disease Chinese Association

Alzheimer Association & Societies in Canada

Products manufactured by the industries:

Three drugs are available to treat symptoms in people with Mild to moderate Alzheimer’s disease

Aricept™ produced by Pfizer Canada Inc.,

Exelon™ produced by Novartis Pharma Canada Inc.

Reminyl™ produced by Janssen Ortho Inc.

Two drugs for Moderate to advanced Alzheimer’s disease:

Ebixa®

Aricept™

Past Conference Report

Euro Dementia 2018

Euro Dementia 2018- Past Report

Conference Series llc LTD takes a great honor in announcing the commencement of 11^th International Conference on Alzheimer’s disease and Dementia on May 24-25, 2018 at Vienna, Austria. Euro Dementia 2018 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Neuroscience. The extremely illustrious conference hosted by Conference Series llc LTD was marked with the attendance of young and brilliant researchers, clinicians, business delegates and talented student communities.

The conference was organized around the theme “Future of Dementia & Alzheimer: Innovations and Research Outlook”. The event implanted a firm relation of upcoming strategies in the field of Neurology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

This annual conference brought together eminent scientists, Neurologist, Neuroscience researchers, health care professionals, University professors, Neuroscience professionals in which many issues in Neuroscience research were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for an open and animated sharing of ideas and experiences.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neuroscience. The eminent personalities at the conference were Don Kulasiri, Lincoln University, New Zealand, V R Badrakalimuthu, Parklands Hospital, UK, Manabu Tamura, Ministry of Economy, Trade and Industry, Japan, Arturo Solís Herrera, Human Photosynthesis® Research Centre, Mexico, Li Zeng, National Neuroscience Institute, Singapore, Nedim Ongun, Burdur State Hospital, Turkey, Ying Wang, China Pharmaceutical University, China, Mario Durán-Prado, University of Castilla-La Mancha, Spain, Santosh Bangar, MIND Clinic for Senior Citizens, India

Conference Series llc LTD offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-Chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Alzheimer’s Disease & Parkinsonism, Journal of Neurology & Neurophysiology and Journal of Neurology and Neuroscience who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the neuroscience research. Conference Series llc LTD therefore, is glad to announce its 15^th International Conference and Exhibition on Alzheimer’s Disease, Dementia & Aging scheduled during April 22-23, 2019 | Rome | Italy.

Mark your calendars for the upcoming meeting.

We are hoping to see you soon!

Past Reports Gallery